Viral Vector Process Development

The Viral Vector Process Development team focuses on developing GMP-compliant production processes and innovative technologies to constantly improve process performance.

• Expertise in AAV (various serotypes) and LV
• Two efficient production platforms:
  • Transient transfection of HEK293 cells in suspension
  • Infection of Sf9 cells in suspension with two Baculoviruses (BEVs system)
• Custom upstream and downstream process development and optimization
• Feasibility study at small scale
• Process scale-up to pilot scale (50L)
• Assessment of innovative upstream and downstream technologies
• Deep process characterization
• Manufacturing of non-GMP materials
• Technology transfer to CMO

Process development experts at your service to set up and improve your manufacturing process !